Recent Trends in Chemotherapy Use and Oncologists’ Treatment Recommendations for Early-Stage Breast Cancer
Kurian AW, Bondarenko I, Jagsi R, Friese CR, McLeod MC, Hawley ST, Hamilton AS, Ward KC, Katz SJ. JNCI: Journal of the National Cancer Institute, 2017 Dec 11, [Epub ahead of print]
Surgeon Influence on Variation in Receipt of Contralateral Prophylactic Mastectomy For Women With Breast Cancer
Katz SJ, Hawley ST, Hamilton AS, Ward KC, Morrow M, Jagsi R, Hofer TP. JAMA Surg. 2018;153(1):29-36.
Jagsi R, Abrahamse PH, Lee KL, Wallner LP, Janz NK, Hamilton AS, Ward KC, Morrow M, Kurian AW, Friese CR, Hawley ST. and Katz SJ. Cancer. 2017 Dec 15;123(24):4791-4799.
What Factors Influence Women’s Perceptions of their Systemic Recurrence Risk after Breast Cancer Treatment?
Lee KL, Janz NK, Zikmund-Fisher BJ, Jagsi R, Wallner LP, Kurian AW, Katz SJ, Abrahamse P, Hawley ST. Med Decis Making. Published online August 17, 2017 [Epub ahead of print].
The association between patient attitudes and values and the strength of consideration for contralateral prophylactic mastectomy in a population-based sample of breast cancer patients
Hawley ST, Griffith KA, Hamilton AS, Ward KC, Morrow M, Janz NK, Katz SJ, Jagsi R. Cancer. 2017 Dec 1;123(23):4547-4555.
Oncologists’ influence on receipt of adjuvant chemotherapy: does it matter whom you see for treatment of curable breast cancer?
Katz SJ, Hawley ST, Bondarenko I, Jagsi R, Ward KC, Hofer TP, Kurian AW. Breast Cancer Res Treat (2017) 165: 751-756.
Wallner LP, Li Y, McLeod MC, Hamilton AS, Ward K C, Veenstra CM, An LC, Janz NK, Katz SJ, Hawley ST. Cancer 2017 October 15;123(20):3895-3903.